PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31384471-1	2019	Selective analogs of the natural glycoside phloridzin are marketed drugs that reduce hyperglycemia in diabetes by inhibiting the active sodium glucose cotransporter SGLT2 in the kidneys.	Glycosides	33-42	solute carrier family 5 member 2	Homo sapiens	165-170	
26180128-11	2015	Since the sodium-glucose cotransporter 2 inhibitors share common structural features, notably a glycoside moiety, investigation of drugs in this class for effects on UGT to identify (or exclude) potential drug-drug interactions is warranted.	Glycosides	96-105	solute carrier family 5 member 2	Homo sapiens	10-40	
25819489-2	2015	Efforts have been made to discover phlorizin-related glycosides with good SGLT2 inhibitory activity.	Glycosides	53-63	solute carrier family 5 member 2	Homo sapiens	74-79	
20149653-0	2010	C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclization.	Glycosides	7-16	solute carrier family 5 member 2	Homo sapiens	31-36	
21090651-2	2010	The best pharmacophore model, generated from eight glycoside inhibitors, was utilized to virtually screen three chemical databases that led to the identification of three non-glycoside SGLT2 inhibitors.	Glycosides	51-60	solute carrier family 5 member 2	Homo sapiens	185-190	
22919717-5	2012	This review will highlight some recent advances and structure-activity relationships in the discovery and development of SGLT-2 inhibitors including O-glycoside, C-glycoside, C, O-spiro glycoside and non glycosides.	Glycosides	204-214	solute carrier family 5 member 2	Homo sapiens	121-127